Research Projects

Characterization of AAV genome integrity and its role in the induction of acute hepatotoxicity upon gene therapy treatment

Dr. Carmen Unzu Curriculum
Researcher Gene Therapy for Hereditary Hearing Loss and AAV Engineering Research Group
Research Division
DNA and RNA Medicine Division
Research group
Gene Therapy for Hereditary Hearing Loss and AAV Engineering. Research Group. Cima

Project information

The project “Characterization of AAV genome integrity and its role in the induction of acute hepatotoxicity following gene therapy treatment” is a project of the Gene Therapy for Hereditary Hearing Loss and AAV Engineering group, which is part of the Gene Therapy Program for Rare Diseases.

Project PID2022-137327OA-I00 funded by:

  • Convocation: Proyectos de Generación de Conocimiento 2022
  • Start date: September 1, 2023
  • End date: August 31, 2026
  • Nature of project: National

Need more information?

If you are interested in learning more about our research, please contact us.